
News|Articles|August 1, 2006
Drug Watch: Agents in late-stage development for the treatment of generalized anxiety disorder and sleep disorders (August 2006) (PDF)
A review of agents in late-stage development for the treatment of generalized anxiety disorder and sleep disorders (August 2006).
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
2
Antipsychotics are effective but can also lead to weight gain, impacting treatment adherence
3
Zabopegdutide shows 62.5% MASH resolution rate at 48 weeks
4
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
5

























